← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2012Last known activity
Jul 23, 2025
Timeline
2000s
- Jan 1, 2005
Cures Within Reach— Founded
Drugs by trial phase (35 distinct, 22 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT07297290CollaboratorPhase 3Jul 23, 2025
- NCT07045493CollaboratorPhase 2Jul 10, 2025
- NCT06499896CollaboratorPhase 2Dec 31, 2024
- NCT06623630CollaboratorPhase 1Nov 30, 2024
- NCT06591091CollaboratorPhase 2Oct 31, 2024
- NCT06579690CollaboratorPhase 3Sep 1, 2024
- NCT05839119CollaboratorPhase 1Oct 2, 2023
- NCT05427695CollaboratorPhase 4Sep 1, 2022
- NCT05272462CollaboratorPhase 2Dec 13, 2021
- NCT04925687CollaboratorPhase 1Jun 1, 2021
- NCT04815187CollaboratorPhase 4Mar 31, 2021
- NCT04721795CollaboratorPhase 2/Phase 3Jan 19, 2021
- NCT07128069CollaboratorN/ADec 28, 2020
- NCT04668950CollaboratorPhase 3Dec 22, 2020
- NCT04915846CollaboratorPhase 1/Phase 2Dec 18, 2020
Details
- Founded
- Chicago, IL, US Jan 1, 2005
- Last known activity
- Jul 23, 2025